Clindamycin vs Nivolumab

## Clindamycin vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Clindamycin** and **Nivolumab**.

## Mechanism of Action

**Clindamycin**: Binds 50S ribosomal subunit inhibiting protein synthesis.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Clindamycin — 2-3 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Clindamycin — C18H33ClN2O5S; Nivolumab — N/A.

**Molecular Weight**: Clindamycin — 424.9830 g/mol; Nivolumab — N/A.

**Type**: Clindamycin — Small molecule; Nivolumab — Antibody.